1887
  1. Home
  2. Eurosurveillance
  3. Volume 24, Issue 29, 18/Jul/2019
  4. Article
Surveillance Open Access
Like 0
Download

Abstract

Background

Since January 2016, a resurgence of measles in Romania has led to the third measles epidemic in the past 12 years; 64 deaths have been confirmed so far–the highest number of measles-related deaths since the measles-mumps-rubella (MMR) vaccine was introduced in 2004.

Aim

To provide an overview on the characterisation on measles in Romania after the introduction of the MMR vaccine with focus on the current outbreak, laboratory and molecular analysis.

Methods

We performed an analysis of measles incidence and mortality after the introduction of MMR vaccination and a retrospective study using serological and molecular data in three consecutive outbreaks with focus on the current outbreak.

Results

In the current outbreak, 17,533 measles cases were notified to the national surveillance system, 93% were unvaccinated. Measles virus was isolated from 429 samples and 283 were genotyped. Genotype B3 was predominant (n = 269) and sporadic measles cases associated with D8 genotype (n = 9) were also observed; genotype D4 and D8 were identified in the previous two measles outbreaks. The detection of several distinct measles virus B3 genotypes suggests multiple virus importations to Romania.

Conclusion

The current outbreak is a consequence of insufficient vaccine coverage. Control measures were implemented to improve uptake of MMR vaccine, including administering the first MMR dose at a younger age (9–11 months) and offering catch-up vaccination to children that have not followed the recommended dosing schedule. More measures are needed to improve the surveillance performance and to achieve high routine MMR vaccination coverage.

© Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2019.24.29.1900041
2019-07-18
2024-04-19
http://instance.metastore.ingenta.com/content/10.2807/1560-7917.ES.2019.24.29.1900041
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/24/29/eurosurv-24-29-4.html?itemId=/content/10.2807/1560-7917.ES.2019.24.29.1900041&mimeType=html&fmt=ahah

References

  1. Cherry JD. Measles virus. In: Cherry JD, eds. Feigin and Cherry’s textbook of pediatric infectious diseases. 7th ed. Vol 2. Philadelphia, PA: Elsevier, 2014.
  2. World Health Organization (WHO). Measles Fact Sheet. Geneva: WHO; September 2017. Available from: http://www.euro.who.int/en/media-centre/sections/press-releases/2017/measles-no-longer-endemic-in-79-of-the-who-european-region
  3. World Health Organization (WHO). Measles and rubella laboratory documents. Geneva: WHO; [accessed 15 Jul 2018]. Available from: http://www.who.int/immunization/monitoring_surveillance/burden/laboratory/measles_resources/en/
  4. Pistol A, Hennessey K, Pitigoi D, Ion-Nedelcu N, Lupulescu E, Walls L, et al. Progress toward measles elimination in Romania after a mass vaccination campaign and implementation of enhanced measles surveillance. J Infect Dis. 2003;187(s1) Suppl 1;S217-22.  https://doi.org/10.1086/368228  PMID: 12721916 
  5. Hennessey KA, Ion-Nedelcu N, Craciun MD, Toma F, Wattigney W, Strebel PM. Measles epidemic in Romania, 1996-1998: assessment of vaccine effectiveness by case-control and cohort studies. Am J Epidemiol. 1999;150(11):1250-7.  https://doi.org/10.1093/oxfordjournals.aje.a009952  PMID: 10588086 
  6. Centers for Disease Control and Prevention (CDC). Measles outbreak—Romania 1997. Atlanta: CDC; 1997. Available from: https://www.cdc.gov/mmwr/preview/mmwrhtml/00050221.htm
  7. World Health Organization (WHO). WHO vaccine-preventable diseases: monitoring system. 2013 global summary. Coverage time series for Romania. Geneva: WHO; [accessed 15 Jul 2018]. Available from: http://apps.who.int/immunization_monitoring/globalsummary/coverages?c=ROU
  8. Romanian National Institute of Public Health (INSP). Analiza evolutiei bolilor transmisibile aflate in supraveghere [Analyzing the evolution of communicable diseases under surveillance]. Bucharest: INSP; 2016. Romanian. Available from https://www.cnscbt.ro/index.php/rapoarte-anuale/779-analiza-evolutiei-bolilor-transmisibile-aflate-in-supraveghere-raport-pentru-anul-2016
  9. European Network on Statelessness. Romania’s stateless children – still unknown, still invisible. Carolina Marin. 11 June 2015. Available from: https://www.statelessness.eu/blog/romania%E2%80%99s-stateless-children-%E2%80%93-still-unknown-still-invisible
  10. Necula G, Lazar M, Stanescu A, Pistol A, Santibanez S, Mankertz A, et al. Transmission and molecular characterisation of wild measles virus in Romania, 2008 to 2012. Euro Surveill. 2013;18(50):20658.  https://doi.org/10.2807/1560-7917.ES2013.18.50.20658  PMID: 24342518 
  11. Hübschen JM, Bork SM, Brown KE, Mankertz A, Santibanez S, Ben Mamou M, et al. Challenges of measles and rubella laboratory diagnostic in the era of elimination. Clin Microbiol Infect. 2017;23(8):511-5.  https://doi.org/10.1016/j.cmi.2017.04.009  PMID: 28412379 
  12. European Commission (EC). Commission implementing decision (EU) No 2018/945 of 22 June 2018 on the communicable diseases and related special health issues to be covered by epidemiological surveillance as well as relevant case definitions. Official Journal of the European Union. Luxembourg: Publications Office of the European Union. 06/07/2018:L170/1. Available from: https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32018D0945&from=EN#page=30
  13. World Health Organization (WHO). Manual for the Laboratory-based Surveillance of Measles, Rubella, and Congenital Rubella Syndrome, Annex 7.1. Geneva: WHO; [accessed 18 Jun 2019] Available from: http://origin.who.int/immunization/monitoring_surveillance/burden/laboratory/Annex_7.1.pdf
  14. Rota PA, Brown K, Mankertz A, Santibanez S, Shulga S, Muller CP, et al. Global distribution of measles genotypes and measles molecular epidemiology. J Infect Dis. 2011;204(Suppl 1):S514-23.  https://doi.org/10.1093/infdis/jir118  PMID: 21666208 
  15. Benson DA, Cavanaugh M, Clark K, Karsch-Mizrachi I, Lipman DJ, Ostell J, et al. GenBank. Nucleic Acids Res. 2013;41(Database issue) D1;D36-42. PMID: 23193287 
  16. World Health Organization (WHO). Nomenclature for describing the genetic characteristics of wild-type measles viruses. Geneva: WHO; [accessed 18 Jun 2019]. Available from: http://apps.who.int/iris/bitstream/10665/231603/1/WER7633_249-251.PDF
  17. Muscat M.Who Gets Measles in Europe?. J Infect Dis.2011;204(Suppl 1):S353-365.
  18. Kremer JR, Brown KE, Jin L, Santibanez S, Shulga SV, Aboudy Y, et al. High genetic diversity of measles virus, World Health Organization European Region, 2005-2006. Emerg Infect Dis. 2008;14(1):107-14.  https://doi.org/10.3201/eid1401.070778  PMID: 18258089 
  19. Mankertz A, Mihneva Z, Gold H, Baumgarte S, Baillot A, Helble R, et al. Spread of measles virus D4-Hamburg, Europe, 2008-2011. Emerg Infect Dis. 2011;17(8):1396-401.  https://doi.org/10.3201/eid1708.101994  PMID: 21801615 
  20. Rota PA, Brown K, Mankertz A, Santibanez S, Shulga S, Muller CP, et al. Global distribution of measles genotypes and measles molecular epidemiology. J Infect Dis. 2011;204(Suppl 1):S514-23.  https://doi.org/10.1093/infdis/jir118  PMID: 21666208 
  21. Santibanez S, Hübschen JM, Ben Mamou MC, Muscat M, Brown KE, Myers R, et al. Molecular surveillance of measles and rubella in the WHO European Region: new challenges in the elimination phase. Clin Microbiol Infect. 2017;23(8):516-23.  https://doi.org/10.1016/j.cmi.2017.06.030  PMID: 28712666 
  22. Amendola A, Bianchi S, Frati ER, Ciceri G, Faccini M, Senatore S, et al. Ongoing large measles outbreak with nosocomial transmission in Milan, northern Italy, March-August 2017. Euro Surveill. 2017;22(33):30596.  https://doi.org/10.2807/1560-7917.ES.2017.22.33.30596  PMID: 28840825 
  23. Wairagkar N, Chowdhury D, Vaidya S, Sikchi S, Shaikh N, Hungund L, et al. , MeaslesNetIndia collaborators. Molecular epidemiology of measles in India, 2005-2010. J Infect Dis. 2011;204(Suppl 1):S403-13.  https://doi.org/10.1093/infdis/jir150  PMID: 21666192 
  24. Avila-Aguero ML, Camacho-Badilla K, Ulloa-Gutierrez R. Measles outbreaks: what does it represent for the elimination strategy in the region of the Americas? A call for the action. Expert Rev Vaccines. 2015;14(8):1043-5.  https://doi.org/10.1586/14760584.2015.1055325  PMID: 26065443 
  25. Kriss JL, Stanescu A, Pistol A, Butu C, Goodson JL. The World Health Organization Measles Programmatic Risk Assessment Tool-Romania, 2015. Risk Anal. 2017;37(6):1096-107.  https://doi.org/10.1111/risa.12669  PMID: 27439071 
  26. Romanian National Institute of Public Health (INSP). Centrul National de Supraveghere si Control al Bolilor Transmisibile Informari saptamanale [National Centre for Communicable Diseases Surveillance and Control, Weekly reports]. Bucharest: INSP; [accessed 18 Jun 2019]. Romanian. Available from: https://cnscbt.ro/index.php/informari-saptamanale/rujeola-1
  27. Dallaire F, De Serres G, Tremblay FW, Markowski F, Tipples G. Long-lasting measles outbreak affecting several unrelated networks of unvaccinated persons. J Infect Dis. 2009;200(10):1602-5.  https://doi.org/10.1086/644783  PMID: 19827945 
  28. Helfand RF, Keyserling HL, Williams I, Murray A, Mei J, Moscatiello C, et al. Comparative detection of measles and rubella IgM and IgG derived from filter paper blood and serum samples. J Med Virol. 2001;65(4):751-7.  https://doi.org/10.1002/jmv.2100  PMID: 11745941 
  29. Roy F, Mendoza L, Hiebert J, McNall RJ, Bankamp B, Connolly S, et al. Rapid identification of measles virus vaccine genotype by real-time PCR. J Clin Microbiol. 2017;55(3):735-43.  https://doi.org/10.1128/JCM.01879-16  PMID: 27852670 
  30. Penedos AR, Myers R, Hadef B, Aladin F, Brown KE. Assessment of the Utility of Whole Genome Sequencing of Measles Virus in the Characterisation of Outbreaks. PLoS One. 2015;10(11):e0143081.  https://doi.org/10.1371/journal.pone.0143081  PMID: 26569100 
Characterisation of measles after the introduction of the combined measles-mumps-rubella (MMR) vaccine in 2004 with focus on the laboratory data, 2016 to 2019 outbreak, Romania
<p class="citation"> <span>Citation style for this article:</span> <span class="meta-value authors"> <a href="/search?value1=Mihaela+Lazar&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Lazar Mihaela</a>, <a href="/search?value1=Aurora+St%C4%83nescu&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Stănescu Aurora</a>, <a href="/search?value1=Ana+Raquel+Penedos&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Penedos Ana Raquel</a>, <a href="/search?value1=Adriana+Pistol&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Pistol Adriana</a></span>. Characterisation of measles after the introduction of the combined measles-mumps-rubella (MMR) vaccine in 2004 with focus on the laboratory data, 2016 to 2019 outbreak, Romania. <a href="/content/ecdc">Euro Surveill.</a> 2019;24(29):pii=1900041. <a href="https://doi.org/10.2807/1560-7917.ES.2019.24.29.1900041" title="doi link" target="_blank">https://doi.org/10.2807/1560-7917.ES.2019.24.29.1900041</a> <span class="ES_Article_citation"> <span class="generated">Received</span>: 10 Jan 2019;&nbsp;&nbsp; <span class="generated">Accepted</span>: 02 Apr 2019 </span> </p>
/content/10.2807/1560-7917.ES.2019.24.29.1900041
/content/10.2807/1560-7917.ES.2019.24.29.1900041
Loading

Data & Media loading...

Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error